-
Immuneering (NASDAQ:IMRX) Earns "Buy" Rating from Needham & Company LLC
来源: Buzz FX / 07 2月 2025 13:01:09 America/Chicago
Immuneering (NASDAQ:IMRX) Earns "Buy" Rating from Needham & Company LLC Written by MarketBeat February 7, 2025 Share Link copied to clipboard. Immuneering ( NASDAQ:IMRX - Get Free Report ) 's stock had its "buy" rating restated by investmen
Read more...